SLC5A2 and diabetes mellitus: SGLT2 inhibitors can block glucose reabsorption in proximal renal tubules, and they have many beneficial effects, including reducing body weight and serum uric acid, lowering blood pressure levels, and weakening glomerular hyperfiltration, which may be related to urinary sodium excretion with diabetes.